MedTrace Logo

Effect of Multi-ingredient on Visceral Adiposity & Non-alcoholic Fatty Liver Disease in Postmenopausal Women With Abdominal Obesity

NCT06377631 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-04-17

No results posted yet for this study

Summary

This study aims to evaluate the effect of daily intake of a specific combination of different natural histidine-related amino acids in combination with dietary recommendations, in the reduction of visceral fat, as well as their associated comorbidities, in postmenopausal women with abdominal obesity.

Conditions

  • Visceral Obesity
  • Non-alcoholic Fatty Liver
  • Postmenopausal

Interventions

DIETARY_SUPPLEMENT

Multi-ingredient of L-histidine, L-serine, L-carnosine and N-Acetylcysteine

The product will be presented in powder format in a single container and with a measuring spoon of the daily dose.

DIETARY_SUPPLEMENT

Placebo

The product will be presented in powder format in a single container and with a measuring spoon of the daily dose.

Sponsors & Collaborators

  • Centre de Diagnosi per la Imatge

    collaborator UNKNOWN

  • Instituto de Investigación Biomédica de Girona (IDIBGI)

    collaborator UNKNOWN

  • Laboratorio de Referencia de Cataluña

    collaborator UNKNOWN

  • Fundació Eurecat

    lead OTHER

Principal Investigators

  • Antoni Caimari, PhD · Fundació Eurecat

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-07
Primary Completion
2025-04-08
Completion
2025-04-08

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06377631 on ClinicalTrials.gov